Jim Simons Outlook Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.22 - $0.66 $23,191 - $69,575	105,418 New	105,418 $42,000
Q3 2022 Nov 14, 2022	SELL	$1.02 - $1.26 $164,322 - $202,986	-161,100 Reduced 76.21%	50,300 $61,000
Q2 2022 Aug 12, 2022	SELL	$0.91 - $2.01 $471,190 - $1.04 Million	-517,792 Reduced 71.01%	211,400 $216,000
Q1 2022 May 13, 2022	SELL	$1.22 - $2.03 $530,823 - $883,255	-435,101 Reduced 37.37%	729,192 $1.3 Million
Q4 2021 Feb 11, 2022	BUY	$1.27 - $2.23 $1.16 Million - $2.03 Million	909,512 Added 356.98%	1,164,293 $1.58 Million

Q3 2021 Nov 12, 2021	BUY	$2.12 - $2.76 $540,135 - $703,195	254,781 New	254,781 $553,000
Q2 2021 Aug 13, 2021	SELL	$1.78 - $2.76 $1.48 Million - $2.3 Million	-832,558 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$0.94 - $3.31 $731,186 - $2.57 Million	777,858 Added 1422.04%	832,558 $1.87 Million
Q4 2020 Feb 10, 2021	SELL	$0.7 - $1.58 $36,470 - $82,318	-52,100 Reduced 48.78%	54,700 $71,000
Q3 2020 Nov 13, 2020	BUY	$0.61 - $1.6 $65,148 - $170,880	106,800 New	106,800 $77,000
Q1 2020 May 14, 2020	SELL	$0.51 - $1.08 $20,094 - $42,552	-39,400 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$0.53 - $1.59 $20,882 - $62,646	39,400 New	39,400 $23,000
Q2 2019 Aug 12, 2019	SELL	$0.91 - $7.68 $10,161 - $85,754	-11,166 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$4.26 - $10.56 $47,567 - $117,912	11,166 New	11,166 $83,000

67.1K

Ticker OTLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,144,992
Market Cap $1.66B
Description
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.